Anbio Biotechnology (NNNN) Receivables - Other (2025)
Anbio Biotechnology (NNNN) posted quarterly Receivables - Other of $948.0 for Q4 2025.
Anbio Biotechnology (NNNN) Receivables - Other (2025) Analysis & Trends
Anbio Biotechnology (NNNN) has reported Receivables - Other for 1 consecutive years, with $948.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Receivables - Other changed N/A year-over-year to $948.0; the TTM figure through Dec 2025 stood at $948.0 (changed N/A YoY), while the FY2025 annual figure was $948.0, changed N/A from the prior year.
- Receivables - Other held at $948.0 in Q4 2025 per NNNN's latest filing.
- Across five years, Receivables - Other topped out at $948.0 in Q4 2025 and bottomed at $948.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Anbio Biotechnology | 301.77 Mn | 289.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 948.00 |
| Dec 31, 2025 | 948.00 |